"Designing Growth Strategies is in our DNA"

Endoprosthesis Market Size, Share & Industry Analysis, By Product Type (Wall Stent Endoprosthesis, Biliary Endoprosthesis, Lower Extremity Endoprosthesis, Upper Extremity Endoprosthesis, Dental Prosthesis), By Age Group (Adults, Pediatrics), By Material (Ceramics, Alloys, Others), By End User (Hospitals & Speciality Clinics, Others) and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI101866 | Status : Ongoing

 

KEY MARKET INSIGHTS

Endoprosthesis are termed as mechanical devices that are placed inside the body in order to replace a missing or damaged body part. These deal with the implantation of artificial mechanical devices within teeth, facial bone, knee, femur, blood vessels and other parts of the body to support the motor control lost as result of any disease or injury or accident. Endoprosthesis have wide-spread applications in hip replacement, joint replacement, knee replacement, femur replacement and others surgeries. According to the Centers for Disease Control and Prevention, the number of total hip replacements among patients aged 45 years and above increased from 138,700 in 2000 to 310,800 in 2010 in the U.S.

Up Arrow

Key Market Driver -

Technological advancements in endoprosthesis devices

Down Arrow

Key Market Restraint -

High cost associated with endoprosthesis devices

The global endoprosthesis market growth is being driven by technological advancements in endoprosthesis devices and increasing awareness about endoprosthesis among people. Moreover, rising incidence of orthopaedic injuries and increasing prevalence of cardiovascular diseases are factors driving the global endoprosthesis market growth. However, the high cost associated with the endoprosthesis devices is a factor that inhibits the global endoprosthesis market growth during the forecast period.

Key Players Covered:

The major companies in the global endoprosthesis market report include Boston Scientific Corporation, Hanger Clinic, Zimmer Biomet, W.L. Gore & Associates, Inc., Smith & Nephew, Ossur Corporate, TRULIFE, College Park Industries, Stryker, DePuy Synthes, Arthrex, Inc., and other players.

Key Insights

  • Incidence of key orthopedic injuries, by key countries, 2018
  • Technological advancements in endoprosthesis
  • Pricing Analysis, by key products / key players
  • key mergers and acquisitions of key companies

Regional Analysis:

The global endoprosthesis market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to dominate the global endoprosthesis market in the forecast years owing to the rapid adoption of technologically advanced healthcare products.

To gain extensive insights into the market, Download for Customization

The global endoprosthesis market is projected to expand in Europe and Asia Pacific, as a result of improving health infrastructure and favourable reimbursement policies in specific countries. Latin America and Middle East & Africa are estimated to project a significant CAGR by the end of the forecast period.

Segmentation

 ATTRIBUTE

 DETAILS

By Product Type

  • Wall Stent Endoprosthesis
  • Biliary Endoprosthesis
  • Lower Extremity Endoprosthesis
  • Upper Extremity Endoprosthesis
  • Dental Prosthesis

By Age Group

  • Adults
  • Pediatrics

By Material

  • Ceramics
  • Alloys
  • Others

By End User

  • Hospitals & ASC’s
  • Speciality Clinics
  • Others

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Endoprosthesis Industry Developments

  • In June 2019, Boston Scientific announced the acquisition of Vertiflex, a company that developed Superion Indirect Decompression System which is used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS).
  • In September 2018, W. L. Gore & Associates announced the acquisition of Pipeline Medical.
  • In September 2016, Zimmer Biomet launched Vanguard an Individualized Design (ID) for total knee arthroplasty (TKA) construction.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann